Lilly’s antidepressant Cymbalta approved for extended use
Published by Food and Drug Administration News November 30th, 2007 in Uncategorized“This approval from the FDA is important because data from our Cymbalta clinical trial demonstrate that continuing to treat the patient delays the time to possible relapse”
Federal regulators have approved Eli Lilly and Co.’s antidepressant medication Cymbalta for long-term use to help patients avoid a relapse into depression, the company said Friday. via WHAS-TV Louisville